课题基金 / 基金详情

THREE PROTEASE INHIBITOR-SPARING REGIMENS FOR THE INITIAL TREATMENT OF HIV

THREE PROTEASE INHIBITOR-SPARING REGIMENS FOR THE INITIAL TREATMENT OF HIV
HIV 初始治疗的三种蛋白酶抑制剂保留方案
批准号:
7377417
负责人:
Christopher D Pilcher
金额:
$6.44万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

Christopher D Pilcher的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG-A5095 - The purpose of this study is to learn: How well each combination of drugs lowers the amount of HIV in blood and keeps it low; and How well drug combinations are tolerated; and How safe the combinations of drugs are.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host Factors Influencing HIV Viral Load and Infectivity in Semen
A Pilot of Intervention to Promote Acute HIV Testing by Ambulatory Care Providers
A Pilot of Intervention to Promote Acute HIV Testing by Ambulatory Care Providers
Host Factors Influencing HIV Viral Load and Infectivity in Semen
国内基金
海外基金
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
  • 批准号:
    31040083
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    肖调义
  • 依托单位: